Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical Industries Limited (IL:TEVA)
:TEVA
Earnings Data
Report Date
Feb 11, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
217.1Last Year’s EPS
255.4Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted continued growth and strong performance in innovative product segments, significant debt reduction, and improved margins. However, there were challenges with TAPI and European generics, alongside a decrease in free cash flow. Despite these challenges, the overall outlook remains positive with reaffirmed future growth targets.Company Guidance
11th Consecutive Quarter of Growth
Revenue increased by 3% to $4.5 billion, adjusted EBITDA grew 6%, and non-GAAP EPS rose 14% compared to Q3 2024.
Strong Performance of Innovative Products
Innovative products reached over $800 million for the quarter, growing 33% year-on-year. AUSTEDO grew 38%, UZEDY was up 24%, and AJOVY increased by 19%.
AUSTEDO's Impressive Growth and Future Outlook
AUSTEDO grew 38% year-over-year to $618 million, with future revenue targets confirmed at $2.5 billion for 2027 and peak sales over $3 billion.
Successful Debt Reduction
Net debt to EBITDA is now below 3x for the first time since 2016, with a target of 2x by 2027.
Improvement in Non-GAAP Gross Margin
Non-GAAP gross margin increased by 120 basis points year-over-year to 55.3%.
IL:TEVA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
IL:TEVA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | 6713.00 | 7867.00 | +17.19% |
Jul 30, 2025 | 5560.00 | 5690.00 | +2.34% |
May 07, 2025 | 6099.00 | 6150.00 | +0.84% |
Jan 29, 2025 | 7960.00 | 6785.00 | -14.76% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Teva Pharmaceutical Industries Limited (IL:TEVA) report earnings?
Teva Pharmaceutical Industries Limited (IL:TEVA) is schdueled to report earning on Feb 11, 2026, Before Open (Confirmed).
What is Teva Pharmaceutical Industries Limited (IL:TEVA) earnings time?
Teva Pharmaceutical Industries Limited (IL:TEVA) earnings time is at Feb 11, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Teva Pharmaceutical Industries Limited stock?
The P/E ratio of Teva is N/A.
What is IL:TEVA EPS forecast?
IL:TEVA EPS forecast for the fiscal quarter 2025 (Q4) is 217.1.